Abstract
This Kalorama Information report, Companion Diagnostics Markets (A Realistic
Assessment of the Opportunities, Challenges, Key Players and Important Trends
in Personalized Medicine) is truly a real-world guide to the potential market
for companion diagnostics.
Essentially the co-development of testing products to enhance the value and
efficacy of a therapeutic, companion diagnostics is widely seen as an
important growth strategy in both the diagnostic and pharmaceutical
industries. It is envisioned as a pathway to personalized medicine, where the
right therapeutic is selected for the right patient. Personalized medicine is
one of the key trends in healthcare, and it' s no surprise that there is great
enthusiasm in many quarters of the in vitro industry, pharmaceutical companies
and the investment community about companion diagnostics. But will the concept
work in the fashion that the industry is envisioning? Who will succeed and
with what strategy? How much can companies expect to earn in this field? What
strategies should companies adopt to thrive in this market?
In this report, Kalorama Information analyst Kenneth Krul, PhD. brings a
real-world view to the concept of companion diagnostics and the likely
scenario given market conditions. He addresses the myriad challenges that
diagnostic and pharmaceutical companies will face in this endeavor. He
outlines strategies that will be more successful. His analysis includes:
- A Complete Explanation of Companion Diagnostics
- Realistic Market Forecasts for the Companion Diagnostics to 2018
- A Glossary of Terms Used in this Industry
- Review of Collaborations Between Pharma and Diagnostic Companies
- Possible Pitfalls the Companion Diagnostic Concept will Face.
- Companies Best Poised to Profit From This Market
- 10 Strategic Conclusions about the Market and Implications for Marketers
- The Key Therapeutic Areas Where Companion Diagnostics Could Succeed.
- The Best Approaches for Companion Diagnostics Marketing
As with all Kalorama Information reports, this report is the result of
analysis from a professional in the industry combined with thorough research
and interviews with experts. Our interview-based methodology uncovers insight
about market not possible from reports based on culled information.
The following companies and their efforts in companion diagnostics are
profiled in this report:
- Abbott Diagnostics
- Affymetrix, Inc
- Agilent Technologies, Inc
- Althea Technologies, Inc
- Curidium Medica plc
- Dako
- Gen Probe
- Genzyme Corporation
- Ipsogen SAS
- Lipomics Technologies, Inc.
- Osmetech plc
- Perlegen Sciences
- Provista Life Sciences
- Qiagen NV
- Singulex, Inc.
- Theranostics Health
- Ventana Medical Systems
| 
View Cart
